Literature DB >> 17238807

Retinal penetration of calpain inhibitors in rats after oral administration.

Yoshihisa Shirasaki1, Masazumi Yamaguchi, Hiroyuki Miyashita.   

Abstract

Calpain-mediated proteolysis has been involved in neuronal cell death of retinal neurological degeneration. An aldehyde-based calpain inhibitor, SJA6017 (1), was effective following oral administration in a rat retinal ischemia model but had low oral bioavailability. The aim of this study was to identify calpain inhibitors with good retinal penetration after oral dosing. The orally bioavailable inhibitors, hemiacetal 3 (SNJ-1715), amphipathic ketoamide 5 (SNJ-1945), and pyridine ketoamide 6 (SNJ-2008), were evaluated for their retinal pharmacokinetic (PK) profiles. The retinal drug exposure of these inhibitors was more than tenfold higher than 1. Among these compounds, 5 exhibited the most favorable retinal PK properties, such as good penetration and long half-life. Comparisons of 5 and the structurally related ketoamide 6 suggested that the presence of a methoxy diethylene glycol moiety resulted in the inhibitor with high penetration into the retina and the sustained high retinal levels. Ketoamide 5 was selected as the development candidate for the treatment of retinal diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17238807     DOI: 10.1089/jop.2006.22.417

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  10 in total

1.  CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.

Authors:  Katherine J Wert; Alexander G Bassuk; Wen-Hsuan Wu; Lokesh Gakhar; Diana Coglan; MaryAnn Mahajan; Shu Wu; Jing Yang; Chyuan-Sheng Lin; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mol Genet       Date:  2015-05-20       Impact factor: 6.150

2.  Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.

Authors:  Nicole Trager; Amena Smith; Gerald Wallace Iv; Mitsuyoshi Azuma; Jun Inoue; Craig Beeson; Azizul Haque; Naren L Banik
Journal:  J Neurochem       Date:  2014-02-12       Impact factor: 5.372

Review 3.  Calpains as mechanistic drivers and therapeutic targets for ocular disease.

Authors:  Jennifer T Vu; Elena Wang; Jolan Wu; Young Joo Sun; Gabriel Velez; Alexander G Bassuk; Soo Hyeon Lee; Vinit B Mahajan
Journal:  Trends Mol Med       Date:  2022-05-29       Impact factor: 15.272

Review 4.  Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy.

Authors:  David Aluja; Sara Delgado-Tomás; Marisol Ruiz-Meana; José A Barrabés; Javier Inserte
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

5.  A new calpain inhibitor protects left ventricular dysfunction induced by mild ischemia-reperfusion in in situ rat hearts.

Authors:  D Takeshita; M Tanaka; S Mitsuyama; Y Yoshikawa; G-X Zhang; K Obata; H Ito; S Taniguchi; Miyako Takaki
Journal:  J Physiol Sci       Date:  2012-12-16       Impact factor: 2.781

6.  Calpain inhibitor SNJ-1945 attenuates events prior to angiogenesis in cultured human retinal endothelial cells.

Authors:  Hong Ma; Ayumi Tochigi; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  J Ocul Pharmacol Ther       Date:  2009-10       Impact factor: 2.671

7.  Degeneration and dysfunction of retinal neurons in acute ocular hypertensive rats: involvement of calpains.

Authors:  Rie Suzuki; Takayuki Oka; Yoshiyuki Tamada; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  J Ocul Pharmacol Ther       Date:  2014-03-24       Impact factor: 2.671

8.  Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly.

Authors:  Shiori Toba; Yasuhisa Tamura; Kanako Kumamoto; Masami Yamada; Keizo Takao; Satoko Hattori; Tsuyoshi Miyakawa; Yosky Kataoka; Mitsuyoshi Azuma; Kiyoshi Hayasaka; Masano Amamoto; Keiko Tominaga; Anthony Wynshaw-Boris; Hideki Wanibuchi; Yuichiro Oka; Makoto Sato; Mitsuhiro Kato; Shinji Hirotsune
Journal:  Sci Rep       Date:  2013-02-06       Impact factor: 4.379

9.  Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis.

Authors:  Amena W Smith; Baerbel Rohrer; Lee Wheless; Supriti Samantaray; Swapan K Ray; Jun Inoue; Mitsuyoshi Azuma; Naren L Banik
Journal:  J Neurochem       Date:  2016-09-27       Impact factor: 5.546

10.  Contribution of Calpain and Caspases to Cell Death in Cultured Monkey RPE Cells.

Authors:  Emi Nakajima; Katherine B Hammond; Masayuki Hirata; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.